Averoa, a biopharmaceutical company bringing innovative therapeutic solutions to people with renal diseases, today announces a positive opinion from the European Medicines

SHL Medical, a world-leading provider of advanced drug delivery systems supporting a broad spectrum of formulations for subcutaneous administration

DDL, a leading provider of package, product, and material testing services, is pleased to announce the opening of a new Good Manufacturing Practice

Vanda Pharmaceuticals Inc. today announced that a New Drug Application (NDA) was submitted to the U.S. Food and Drug Administration (FDA)

IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing

Turn Biotechnologies, a pioneer in epigenetic reprogramming, announced the acquisition of groundbreaking ARMMs (ARRDC1 Mediated Microvesicles) technology

GV20 Therapeutics (GV20), a clinical-stage AI-powered biotherapeutics company, has entered into a strategic research collaboration

Xcell Biosciences Australia Pty Ltd (Xcellbio), an Australian affiliate of the San Francisco-based instrumentation company focused on cell and gene therapy applications

Primrose Bio, Inc. a company developing proprietary therapeutic manufacturing technologies, announces the launch of Prima RNApols™ ExTend

Yoda Therapeutics Inc. (YODA), an AI-driven company that focuses on Central Nervous System (CNS) drugs